Vertex Pharmaceuticals Incorporated
VRTXLast close · Oct 16, 2026499.74−9.01 (−1.77%)
Market cap$126.7B
Of the 85 managers this site tracks, 3 held Vertex Pharmaceuticals (VRTX) at the end of Q2 2026, their latest 13Fs. The largest position by value was Tweedy Browne's, $19.9M; Torray's ($7.6M) and Bridgewater's ($5.4M) follow. No Schedule 13D or 13G is on file for VRTX from the activists and large holders the site follows.
Superinvestors holding VRTX
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Tweedy Browne | Tweedy, Browne Co LLC | Q2 2026 | 40,121 | $19.9M |
| Torray | Torray Investment Partners LLC | Q2 2026 | 15,215 | $7.6M |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 10,865 | $5.4M |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.